jRCTs031220724
Untitled Trial
A Phase2 study to investigate the efficacy and safety of Atezolizumab and bevacizumab with live bacterial product for unresectable HCC
Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Interventional
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCTs031220724
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCTs031220724 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.